SLC6A1 Svizzera

Founded in 2025, SLC6A1 Svizzera is a non-profit association based in Intragna, Switzerland working on health, medical research.

SLC6A1 Svizzera is a non-profit patient association in Switzerland dedicated to the SLC6A1 gene mutation, a rare genetic neurodevelopmental disorder. Founded on 8 March 2025 and based in Locarno, Ticino, it supports affected families through information, peer support and community meetings, raises awareness among families and healthcare professionals, and promotes and funds research into targeted therapies. It is a founding member of the SLC6A1 Europe alliance and a member of ProRaris and EURORDIS, and it organises events such as an annual meeting and fundraising evenings. It also advocates for access to treatments such as sodium phenylbutyrate in Switzerland, and promotes genetic testing for early diagnosis.